End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24,400 KRW | -0.41% | -0.81% | -9.63% |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
2023 | Tranche Update on Korea United Pharm Inc.'s Equity Buyback Plan announced on July 15, 2022. | CI |
Sales 2015 | 162B 118M | Sales 2016 * | 177B 129M | Capitalization | 359B 262M |
---|---|---|---|---|---|
Net income 2015 * | 19B 13.89M | Net income 2016 * | 18B 13.16M | EV / Sales 2015 | 1.65 x |
Net cash position 2015 * | 26.3B 19.23M | Net cash position 2016 * | 19.04B 13.91M | EV / Sales 2016 * | 1.92 x |
P/E ratio 2015 |
12.6
x | P/E ratio 2016 * |
21.8
x | Employees | 665 |
Yield 2015 |
1.26% | Yield 2016 * |
0.98% | Free-Float | 52.41% |
1 day | -0.41% | ||
1 week | -0.81% | ||
Current month | -1.21% | ||
1 month | +5.17% | ||
3 months | -1.21% | ||
6 months | -3.56% | ||
Current year | -9.63% |
Managers | Title | Age | Since |
---|---|---|---|
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Won-Tae Jeong
BRD | Director/Board Member | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Duk-Young Kang
CEO | Chief Executive Officer | 77 | - |
Gui-Ja Kim
BRD | Director/Board Member | 67 | - |
Won-Ho Kang
CEO | Chief Executive Officer | 47 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 24,400 | -0.41% | 31,382 |
24-05-09 | 24,500 | -0.41% | 22,317 |
24-05-08 | 24,600 | -0.20% | 23,784 |
24-05-07 | 24,650 | -0.20% | 25,913 |
End-of-day quote Korea S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.63% | 262M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+18.77% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- A033270 Stock